Publications

Poster presentation of the positive efficacy, tolerability and palatability results for the ferric maltol pediatric FORTIS clinical trial at the American Association of Pediatrics (AAP) National Conference on 29th September 2025 in Denver, Colorado.

Post Hoc analysis of a Multicenter, Open-Label, Randomized, Phase 1 Clinical Study

Post hoc analysis of a multicenter, open-label, randomized, Phase 1 clinical study

A pooled analysis of early and sustained response in patients with IBD with iron deficiency anemia who were treated with ferric maltol.

Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion

Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension

Safety, Tolerability, and Pharmacokinetics of Oral Ferric Maltol in Children With Iron Deficiency: Phase 1 Study

Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease.

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic

Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron

Health care resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease

Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: a comparison of ferric maltol and IV iron

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study

Ferric Maltol Is Effective in Correcting Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results from a Phase-3 Clinical Trial Program